Protein and peptide profiling as a tool for biomarker discovery in depression.
about
Multiplatform metabolome and proteome profiling identifies serum metabolite and protein signatures as prospective biomarkers for schizophrenia.The contribution of proteomic studies in humans, animal models, and after antidepressant treatments to investigate the molecular neurobiology of major depression.The promise of biomarkers in diagnosing major depression in primary care: the present and future.Proteomics insight into psychiatric disorders: an update on biological fluid biomarkers.Proteomics for blood biomarker exploration of severe mental illness: pitfalls of the past and potential for the future
P2860
Protein and peptide profiling as a tool for biomarker discovery in depression.
description
2012 nî lūn-bûn
@nan
2012 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Protein and peptide profiling as a tool for biomarker discovery in depression.
@ast
Protein and peptide profiling as a tool for biomarker discovery in depression.
@en
Protein and peptide profiling as a tool for biomarker discovery in depression.
@nl
type
label
Protein and peptide profiling as a tool for biomarker discovery in depression.
@ast
Protein and peptide profiling as a tool for biomarker discovery in depression.
@en
Protein and peptide profiling as a tool for biomarker discovery in depression.
@nl
prefLabel
Protein and peptide profiling as a tool for biomarker discovery in depression.
@ast
Protein and peptide profiling as a tool for biomarker discovery in depression.
@en
Protein and peptide profiling as a tool for biomarker discovery in depression.
@nl
P2093
P2860
P356
P1433
P1476
Protein and peptide profiling as a tool for biomarker discovery in depression.
@en
P2093
Johannes Thome
Khaled Alawam
Rossen Donev
P2860
P304
P356
10.1002/ELPS.201200248
P577
2012-11-22T00:00:00Z